शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans

This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →

BSEBIOGEN PHARMACHEM INDUSTRIES L· FinanceHighNeutral
Announced Tue, 3 Nov, 2026 · 15:21 IST

Standalone Sep 2026 quarter: nil revenue; profit after tax 25.73 lakh versus 49.15 lakh loss

Negative operating cash flowResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.0%Reaction day
₹0.25
prior close
₹0.25
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.3%-0.3% vs market
Other Financial Services peers, median of 80sector+0.0%+0.0% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and in line with its Other Financial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-4.0
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.0+0.3-0.3+0.0+0.0
Next day
+0.0+2.4-2.4+0.0+0.0
2d
+4.0+3.6+0.4+0.3+3.7
3d
+8.0pendingpending+0.1+7.9
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Other Financial Services peers, median of 80Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

On a standalone basis for the quarter ended 30 September 2026, operating revenue was nil, unchanged year on year; other income was 28.33 lakh versus negative 10.49 lakh, and profit after tax was 25.73 lakh versus a 49.15 lakh loss. Standalone half-year revenue was nil; profit after tax was 47.87 lakh versus 85.33 lakh a year earlier, operating cash flow positive 122.24 lakh and borrowings nil. Prior-period figures were regrouped or recast.

Likely market impact

Positive for sentiment as the quarter returned to profit, but nil operating revenue shows the core business remains inactive.

By the numbersStandalone · Q2 FY27 vs Q2 FY26
Q2 FY27Q2 FY26Change
Revenue₹0.00 Cr₹0.00 Crunchanged
Operating profit−₹0.03 Cr−₹0.39 Crloss narrowed
Profit after tax₹0.26 Cr−₹0.49 Crturned positive
EBITDA margin———

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.